405 related articles for article (PubMed ID: 18446509)
1. Prodrug approaches for CNS delivery.
Rautio J; Laine K; Gynther M; Savolainen J
AAPS J; 2008; 10(1):92-102. PubMed ID: 18446509
[TBL] [Abstract][Full Text] [Related]
2. Prodrugs: design and clinical applications.
Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
[TBL] [Abstract][Full Text] [Related]
3. Progress in drug delivery to the central nervous system by the prodrug approach.
Pavan B; Dalpiaz A; Ciliberti N; Biondi C; Manfredini S; Vertuani S
Molecules; 2008 May; 13(5):1035-65. PubMed ID: 18560328
[TBL] [Abstract][Full Text] [Related]
4. Prodrug approaches to reduce hyperexcitation in the CNS.
Vytla D; Combs-Bachmann RE; Hussey AM; McCarron ST; McCarthy DS; Chambers JJ
Adv Drug Deliv Rev; 2012 May; 64(7):666-85. PubMed ID: 22138074
[TBL] [Abstract][Full Text] [Related]
5. Prodrugs: a challenge for the drug development.
Zawilska JB; Wojcieszak J; Olejniczak AB
Pharmacol Rep; 2013; 65(1):1-14. PubMed ID: 23563019
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in prodrugs as drug delivery systems.
Lin C; Sunkara G; Cannon JB; Ranade V
Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
[TBL] [Abstract][Full Text] [Related]
7. Prodrugs--from serendipity to rational design.
Huttunen KM; Raunio H; Rautio J
Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
[TBL] [Abstract][Full Text] [Related]
8. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS.
Perioli L; Ambrogi V; Bernardini C; Grandolini G; Ricci M; Giovagnoli S; Rossi C
Eur J Med Chem; 2004 Aug; 39(8):715-27. PubMed ID: 15276305
[TBL] [Abstract][Full Text] [Related]
9. Approaches towards enhanced transepithelial drug delivery.
Majumdar S; Mitra AK
Discov Med; 2006 Dec; 6(36):229-33. PubMed ID: 17250788
[TBL] [Abstract][Full Text] [Related]
10. Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
Müller CE
Chem Biodivers; 2009 Nov; 6(11):2071-83. PubMed ID: 19937841
[TBL] [Abstract][Full Text] [Related]
11. Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach.
Dahan A; Khamis M; Agbaria R; Karaman R
Expert Opin Drug Deliv; 2012 Aug; 9(8):1001-13. PubMed ID: 22703376
[TBL] [Abstract][Full Text] [Related]
12. Prodrug design of phenolic drugs.
Férriz JM; Vinsová J
Curr Pharm Des; 2010; 16(18):2033-52. PubMed ID: 20443775
[TBL] [Abstract][Full Text] [Related]
13. What should be considered on design of a colon-specific prodrug?
Jung Y; Kim YM
Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
[TBL] [Abstract][Full Text] [Related]
14. Prodrugs: effective solutions for solubility, permeability and targeting challenges.
Hu L
IDrugs; 2004 Aug; 7(8):736-42. PubMed ID: 15334306
[TBL] [Abstract][Full Text] [Related]
15. Prodrug Strategies in the CNS Drugs: Small Modification Makes Big Improvements.
Kang T; Miao Z; Liu S; Ke B
Curr Top Med Chem; 2021; 21(24):2157-2169. PubMed ID: 34315372
[TBL] [Abstract][Full Text] [Related]
16. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
Jana S; Mandlekar S; Marathe P
Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the mechanism of enhancement of central nervous system delivery of 2'-beta-fluoro-2',3'-dideoxyinosine via a blood-brain barrier adenosine deaminase-activated prodrug.
Johnson MD; Chen J; Anderson BD
Drug Metab Dispos; 2002 Feb; 30(2):191-8. PubMed ID: 11792690
[TBL] [Abstract][Full Text] [Related]
19. Prodrug approaches to the improved delivery of peptide drugs.
Wang W; Jiang J; Ballard CE; Wang B
Curr Pharm Des; 1999 Apr; 5(4):265-87. PubMed ID: 10101225
[TBL] [Abstract][Full Text] [Related]
20. Targeted prodrug design to optimize drug delivery.
Han HK; Amidon GL
AAPS PharmSci; 2000; 2(1):E6. PubMed ID: 11741222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]